Sign in
Taking people in FrancePhase 4

Lidocaine through a vein plus ropivacaine at incision sites after colorectal cancer surgery

Tests lidocaine with ropivacaine for recovery after keyhole colorectal cancer surgery in adults.

Key facts

Who runs it
Centre Hospitalier Universitaire Amiens Picardie
Where
Amiens Cedex 1, FranceSee the site
Registry title
Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic surgery: a randomized controlled trial
Status
Recruiting
Phase
Phase 4
People taking part
182 people, planned
Started
24 Apr 2026
Expected to end
1 Jul 2028
Type of study
Interventional
Record updated
22 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having planned keyhole (laparoscopic) surgery for colorectal cancer. It tests IV lidocaine plus ropivacaine at the cut sites for recovery.

Age
18 years or older
Sex
All sexes
Disease stage
Colorectal cancer, scheduled for laparoscopic surgery.
Earlier treatment
People who used opioids or opioid-like drugs before surgery cannot join.

Main reasons for not taking part

  • Allergy or contraindication to lidocaine, ropivacaine or the other listed drugs
  • Surgery by open cut (laparotomy), or surgery not for cancer
  • Chronic pain lasting more than 3 months
  • Psychiatric disorders
  • Pregnant or breastfeeding women

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Patients undergoing scheduled laparoscopic colorectal cancer surgery
  • Patients aged 18 years or older
  • Highly effective method of contraception for women of childbearing age (combined hormonal contraception (estrogen and progesterone) combined with ovulation inhibition (oral, intravaginal, transdermal), hormonal contraception (progesterone only) combined with ovulation inhibition (oral, injectable, implantable), intrauterine device, intrauterine hormone-releasing system, bilateral fallopian tube occlusion, vasectomized partner, sexual abstinence
  • Informed consent and signed agreement
  • Enrollment in a Social Security plan

Who cannot take part

  • Colorectal surgery by laparotomy
  • Allergy or contraindication to lidocaine or ropivacaine,
  • Allergy or contraindication to paracetamol, nefopam, ketamine, propofol, dexamethasone, sufentanil , Celebrex or Parecoxib, , morphine derivatives, and Colorectal surgery by laparotomy
  • Colorectal surgery not indicated for cancer treatment
  • Patients suffering from psychiatric disorders
  • Patients under guardianship, conservatorship, or legal protection
  • Chronic preoperative pain (defined as pain persisting for more than 3 months),
  • Preoperative use of opioids or opioid derivatives,
  • Patients for whom pain self-assessment using a self-assessment scale cannot be performed (non-communicative, non-English-speaking, etc.)
  • Pregnant or breastfeeding women

This trial is currently available in France.

  • Centre Hospitalier Universitaire Amiens PicardieAmiens Cedex 1, FranceTaking people

About the trial

What the trial wants to find out

Evaluate the effectiveness of combining intravenous lidocaine and ropivacaine infiltration of laparoscopic trocar sites on postoperative recovery as assessed using the QOR-15 twenty-four hours after colorectal surgery.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic surgery: a randomized controlled trial
Plain-language title
Lidocaine through a vein plus ropivacaine at incision sites after colorectal cancer surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
22 September 2026